The Nomination Committee, which has been appointed in accordance with the principles adopted by the Annual General Meeting on May 17, 2021, consists of:
- William Gunnarsson, appointed by BWG Invest Sàrl
- Rolf Karlsson, appointed by FV Group AB
- Peter Thelin, appointed by Sjuenda Holding AB
- Thomas Pollare (Chairman of the Board)
The Nomination Committee shall, before the Annual General Meeting 2023, prepare decisions on election and remuneration issues and, where applicable, procedural issues for the next Nomination Committee.
Shareholders who wish to submit proposals to the Nomination Committee before the Annual General Meeting on May 17, 2023, can do so by e-mail to birgitta.lundvik@alzecurepharma.com Proposals must be submitted to the Nomination Committee before 23 March 2023.
For further information, please contact:
Thomas Pollare, Chairman of the Board, AlzeCure Pharma AB
Mobil: +46(0)70-810 79 29
Email: thomas.pollare@alzecurepharma.com